An FDA investigator noted for his meticulous and detail-oriented approach to uncovering fraud, particularly through digital data analysis, setting a trend within the agency.

A whistleblower and former Ranbaxy employee who uncovered significant fraud and regulatory violations at the company, contributing to a major investigation and subsequent fine.

An Indian pharmaceutical company known for its production of generic drugs and a culture prioritizing profit over quality, involved in unethical practices and regulatory violations.

A former process chemist at Ranbaxy, known for his quick problem-solving skills, who later brought controversial practices to another generic drug company.

A governmental agency tasked with protecting public health, portrayed as both a gold standard in drug regulation and plagued by its own bureaucratic challenges and historical inadequacies.

The CEO of Ranbaxy, characterized by his ambitious and competitive nature, focused on profit and expansion, often through unethical means.